Distinct Laboratory and Clinical Features of Metabolic and Alcohol-Related Liver Disease (MetALD): A Systematic Review and Meta-Analysis
Maria Tampaki, Vasileios Lekakis, Christos Chologkitas, Stergios Α. Polyzos, Evangelos Cholongitas
TL;DR
This study compares the liver disease MetALD with MASLD and ALD, finding distinct lab and metabolic features that suggest MetALD is a unique condition.
Contribution
The study identifies specific laboratory and metabolic differences between MetALD and other liver diseases, supporting its classification as a distinct subtype.
Findings
MetALD shows higher AST, ALT, GGT, triglycerides, and HDL-C compared to MASLD.
Compared to ALD, MetALD has lower liver enzymes but similar metabolic parameters.
MetALD has lower BMI and HbA1c than MASLD but higher blood pressure.
Abstract
We aimed to perform a systematic review and meta-analysis of observational studies, primarily to compare laboratory findings, including liver function tests, and metabolic parameters, between patients with Metabolic and alcohol-related/associated liver disease (MetALD) and those with metabolic dysfunction-associated steatotic liver disease (MASLD) or alcohol-related liver disease (ALD). MetALD is a newly recognized subtype of steatotic liver disease (SLD) characterized by the synergistic impact of metabolic dysfunction and alcohol consumption. Data on its clinical and laboratory profile remain limited. Thirty-three studies including 7,504,674 individuals were analyzed. Compared to MASLD, MetALD was associated with higher aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma glutamyl transferase (GGT), higher triglycerides (TG) and high density lipoprotein-cholesterol…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 10
Figure 11
Figure 12
Figure 13
Figure 14
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAlcohol Consumption and Health Effects · Liver Disease Diagnosis and Treatment · Drug-Induced Hepatotoxicity and Protection